Related Posts
FDA approves Cobenfy: A breakthrough Schizophrenia treatment after decades
The US FDA has approved Bristol Myers Squibb’s oral medicine, Cobenfy, for treating schizophrenia in adults. This is the first new type of medication in […]
Lumax to acquire majority stake in Greenfuel Energy Solutions
Lumax Auto Technologies has entered into an agreement to acquire a majority stake in Greenfuel Energy Solutions. This acquisition will help Lumax enter the expanding […]
Infosys rolls out 5-8% increments
- staff
- February 26, 2025
- 0
Infosys has announced salary hikes of 5% to 8% for employees ranging from junior to senior roles up to job level 7, with top performers […]